MEDI-FIRST
- Product NDC
- 71927-019
- 11-digit product format
- 719270019
- Labeler code
- 71927
- Product ID
- 71927-019_5abd4200-f481-aca6-e063-6294a90ac4bc
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Benzalkonium Chloride, Lidocaine
- Dosage form
- CREAM
- Route
- TOPICAL
- Labeler
- Orazen Inc
- Application
- M017
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2025-08-29
- Substance
- LIDOCAINE HYDROCHLORIDE; BENZALKONIUM CHLORIDE
- Active strength
- 5; 1.3 mg/g; mg/g
- Pharmacologic classes
- Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Code | Status | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | I | Inactivated by FDA | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | I | Inactivated by FDA | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 71927-019-03 | I | Inactivated by FDA | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 71927-019-02 | I | Inactivated by FDA | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | I | Inactivated by FDA | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | I | Inactivated by FDA | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 71927-019-03 | I | Inactivated by FDA | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 71927-019-02 | I | Inactivated by FDA | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | I | Inactivated by FDA | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | I | Inactivated by FDA | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 71927-019-03 | I | Inactivated by FDA | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 71927-019-02 | I | Inactivated by FDA | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | I | Inactivated by FDA | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | I | Inactivated by FDA | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 71927-019-03 | I | Inactivated by FDA | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 71927-019-02 | I | Inactivated by FDA | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | I | Inactivated by FDA | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | I | Inactivated by FDA | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 71927-019-03 | I | Inactivated by FDA | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 71927-019-02 | I | Inactivated by FDA | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | U | Excluded because listing certification expired | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | U | Excluded because listing certification expired | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 71927-019-02 | U | Excluded because listing certification expired | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 71927-019-03 | U | Excluded because listing certification expired | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 71927-019-02 | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 71927-019-03 | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 71927-019-02 | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 71927-019-03 | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- MEDI-FIRST
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| LIDOCAINE HYDROCHLORIDE | 5 mg/g |
| BENZALKONIUM CHLORIDE | 1.3 mg/g |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| V13007Z41A | Internal UNII lookup |
| F5UM2KM3W7 | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1012100 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| f508434f-5948-7134-e053-2a95a90a03d7 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 860a93dc-4863-49cc-b284-6bbe8191bc48 | Product name | 4 | 20250214 |
| eaba870a-6a9d-442e-8643-87b3f558a451 | Product name | 1 | 20250117 |
| 9b4cf230-fd05-41d5-98c6-5db9ecb27b86 | Product name | 1 | 20230117 |
| fa8b5901-e681-426f-82fe-54f6d81ec698 | Product name | 4 | 20180619 |
| 332d03e4-aa24-4b11-841a-02bf41081920 | Product name | 1 | 20171221 |
| c08ab52f-2fc8-4409-9d9f-ed8edc0bd070 | Product name | 1 | 20171221 |
| 68ed98f8-24c2-44a0-944a-6d36e82ce25a | Product name | 1 | 20141222 |
| 1cd42bc2-a430-c72b-636d-991b235fbf80 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71927-019-01 | MEDI-FIRST | 0.9 g in 1 POUCH | CREAM | 0.9 | 2 | |
| 71927-019-01 | MEDI-FIRST | 0.9 g in 1 POUCH | CREAM | 0.9 | 2 | |
| 71927-019-02 | MEDI-FIRST | 25 in 1 BOX | CREAM | 25 | 2 | |
| 71927-019-03 | MEDI-FIRST | 25 in 1 BOX | CREAM | 25 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 71927-019 | MEDI-FIRST (BENZALKONIUM CHLORIDE, LIDOCAINE) CREAM [ORAZEN INC] | 1 | Current NDC, 2 package rows | 20230221_f522fb0b-3d86-b228-e053-2a95a90a55e9.zip |
| 71927-019 | MEDI-FIRST (BENZALKONIUM CHLORIDE, LIDOCAINE) CREAM [ORAZEN INC] | 1 | Current NDC, 2 package rows | 20230220_f508434f-5948-7134-e053-2a95a90a03d7.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Family Care Anti-Itch | HYDROCORTISONE | United Exchange Corp. | 8e4d46d8-7084-0666-e053-2995a90ad520 | 2025-10-21 | Warnings | M017 |
| Coralite Pain Relief | CAMPHOR, MENTHOL, METHYL SALICYLATE | United Exchange Corp. | 69aec845-3d4c-d226-e053-2991aa0afd12 | 2025-10-21 | Warnings | M017 |
| WHITE FLOWER ANALGESIC BALM | CAMPHOR, MENTHOL AND METHYL SALICYLATE | HOE HIN PAK FAH YEOW MANUFACTORY LTD | f3e3b8b5-b12b-49ac-9318-b0c358b136e9 | 2025-10-21 | Warnings | M017 |
| Mountain Ice Sports Recovery | MENTHOL | Mountainside Medical Equipment, Inc. | 98638529-3c17-436e-901f-c8aea52bdab6 | 2025-10-20 | Warnings | M017 |
| Lip Clear Lysine Plus | MENTHOL, UNSPECIFIED FORM | Quantum, Inc. | 21a5b4fb-baed-4766-9820-5c6051c14720 | 2025-10-20 | Warnings | M017 |
| Buzz Away Sting Soothe | MENTHOL | Quantum, Inc. | 419e34ea-17b2-ec32-e063-6394a90a603d | 2025-10-20 | Warnings | M017 |
| Family Care Anti-Itch | HYDROCORTISONE | United Exchange Corp. | deb09e89-9794-89a7-e053-2a95a90abdf8 | 2025-10-20 | Warnings | M017 |
| Numbing Cream | MENTHOL | FlexiGo Inc | 41571c8f-332b-f423-e063-6394a90a8897 | 2025-10-20 | Warnings | M017 |
| Soothing Nerve Therapy | MENTHOL | Wise Consumer Products | 40829d6b-5005-7ec9-e063-6294a90a970e | 2025-10-20 | Warnings | M017 |
| Numbing Cream | MENTHOL | FlexiGo Inc | 4146fd51-b18c-393d-e063-6294a90a4d9a | 2025-10-20 | Warnings | M017 |
| Lidocaine 4% Maximum OTC Strength | LIDOCAINE | Cardinal Health 107, LLC | 975031df-d46d-4098-b1c0-1c0c92b41995 | 2025-10-20 | Warnings | M017 |
| Cortizone 10 Intensive Healing | HYDROCORTISONE | Chattem, Inc. | bb3d1a3e-4c0c-4694-9c05-80152dd9bd1c | 2025-10-20 | Warnings | M017 |
| Sting relief pad | BENZOCAINE, ALCOHOL | Guangdong Comfort Medical Products Co., Ltd. | 6e905065-10a9-1ded-e053-2a91aa0a46a1 | 2025-10-19 | Warnings | M017 |
| CVS Cold and Hot | MENTHOL | CVS Pharmacy | a44cec95-822a-40b6-e053-2995a90ae31c | 2025-10-17 | Warnings | M017 |
| Sombra Max | SOMBRA MAX | Sombra Cosmetics Inc. | 41623a46-e6e7-907e-e063-6394a90afc4c | 2025-10-17 | Warnings | M017 |
| POMADA DRAGON PAIN RELIEVING | CAMPHOR (SYNTHETIC), MENTHOL, METHYL SALICYLATE | TELEVISA CONSUMER PRODUCTS USA | c283291d-feaa-4f89-8fde-9e3957ea8b9f | 2025-10-17 | Warnings | M017 |
| Ear Pain MD | LIDOCAINE HYDROCHLORIDE | Eosera Inc | 78c4418f-7f0f-447f-a94f-d4c89a081af1 | 2025-10-17 | Warnings | M017 |
| WOFANLI Quit Smoking Nicotine Patches | NICOTINE TRANSDERMAL PATCHES | Shenzhen Paxi Trading Co., Ltd. | 414217c1-ff3a-b556-e063-6394a90aa5db | 2025-10-16 | Warnings | M017 |
| WOFANLI Quit Smoking Nicotine Patches | NICOTINE TRANSDERMAL PATCHES | Shenzhen Paxi Trading Co., Ltd. | 41422d04-160b-51b2-e063-6294a90ab2b2 | 2025-10-16 | Warnings | M017 |
| WOFANLI Quit Smoking Nicotine Patches | NICOTINE TRANSDERMAL PATCHES | Shenzhen Paxi Trading Co., Ltd. | 41427275-4c35-bbdf-e063-6294a90a14cf | 2025-10-16 | Warnings | M017 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1012100 | benzalkonium chloride 0.13 % / lidocaine HCl 0.5 % Topical Cream | PSN | f508434f-5948-7134-e053-2a95a90a03d7 | 2 |
| 1012100 | benzalkonium chloride 0.13 % / lidocaine HCl 0.5 % Topical Cream | PSN | f522fb0b-3d86-b228-e053-2a95a90a55e9 | 2 |
| 1012100 | benzalkonium chloride 1.3 MG/ML / lidocaine hydrochloride 5 MG/ML Topical Cream | SCD | f508434f-5948-7134-e053-2a95a90a03d7 | 2 |
| 1012100 | benzalkonium chloride 1.3 MG/ML / lidocaine hydrochloride 5 MG/ML Topical Cream | SCD | f522fb0b-3d86-b228-e053-2a95a90a55e9 | 2 |
| 1012100 | benzalkonium chloride 0.13 % / lidocaine hydrochloride 0.5 % Topical Cream | SY | f508434f-5948-7134-e053-2a95a90a03d7 | 2 |
| 1012100 | benzalkonium chloride 0.13 % / lidocaine hydrochloride 0.5 % Topical Cream | SY | f522fb0b-3d86-b228-e053-2a95a90a55e9 | 2 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 71927-019-01 | 71927001901 | 0.9 g in 1 POUCH | 0.9 g | Historical | |||
| 71927-019-02 | 71927001902 | 25 POUCH in 1 BOX (71927-019-02) / .9 g in 1 POUCH (71927-019-01) | 25 pouch | 2025-08-29 | No | No | Current |
| 71927-019-03 | 71927001903 | 25 POUCH in 1 BOX (71927-019-03) / .9 g in 1 POUCH (71927-019-01) | 25 pouch | 2025-09-03 | No | No | Current |